Bausch Health Companies Inc. (BHC) Social Stream
BAUSCH HEALTH COMPANIES INC (BHC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BAUSCH HEALTH COMPANIES INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-14 | 8 | $55 | $27 | $38.444 | $7.69 | 399.92% |
| 2022-01-13 | 6 | $55 | $31 | $40.142 | $7.69 | 422% |
| 2022-01-20 | 5 | $55 | $31 | $40.142 | $7.69 | 422% |
| 2022-02-09 | 5 | $55 | $27.001 | $38.5 | $7.69 | 400.65% |
| 2022-05-11 | 6 | $55 | $25 | $37.5 | $7.69 | 387.65% |
| 2022-06-08 | 6 | $55 | $7 | $31.333 | $7.69 | 307.45% |
| 2022-06-13 | 7 | $55 | $7 | $29.4 | $7.69 | 282.31% |
| 2022-07-26 | 7 | $40 | $7 | $21.5 | $7.69 | 179.58% |
| 2022-07-28 | 7 | $40 | $7 | $19.428 | $7.69 | 152.64% |
| 2022-07-29 | 6 | $40 | $5 | $18.666 | $7.69 | 142.73% |
| 2022-08-10 | 7 | $40 | $5 | $18.666 | $7.69 | 142.73% |
| 2022-08-24 | 7 | $40 | $4.5 | $13.25 | $7.69 | 72.3% |
| 2022-09-01 | 7 | $40 | $5 | $13.833 | $7.69 | 79.88% |
| 2022-10-14 | 7 | $40 | $5 | $13.666 | $7.69 | 77.71% |
| 2022-10-20 | 8 | $40 | $5 | $12.714 | $7.69 | 65.33% |
| 2022-11-03 | 8 | $40 | $6 | $12 | $7.69 | 56.05% |
| 2023-01-27 | 8 | $35 | $6 | $11.25 | $7.69 | 46.29% |
The Trend in the Analyst Price Target
Over the past 13 months, BHC's average price target has gone down $28.89.
BHC reports an average of 150.62% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-13 | 6 | 55 | 7 | 29.400 | 7.58 | 287.86% |
| 2022-06-13 | 7 | 55 | 7 | 29.400 | 7.58 | 287.86% |
| 2022-09-17 | 7 | 40 | 5 | 13.666 | 7.38 | 85.18% |
| 2022-10-14 | 7 | 40 | 5 | 13.666 | 6.45 | 111.88% |
| 2023-01-27 | 8 | 35 | 6 | 11.250 | 8.38 | 34.25% |
BHC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.63 | 2 | 0 | 5 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
BHC's average broker recommendation rating worsened by 0.84 over the prior 34 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BHC as an investment opportunity.
- BAUSCH HEALTH COMPANIES INC's variance in analysts' estimates is lower than -2158.66% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the large market cap category, BAUSCH HEALTH COMPANIES INC's upside potential (average analyst target price relative to current price) is greater than 2314.43% of them.
- In terms of how BAUSCH HEALTH COMPANIES INC fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 294.5% of that group.
- BHC has a higher average analyst price target than 346.94% of stocks in the large market cap category.
Stocks similar to BAUSCH HEALTH COMPANIES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VRTX, IONS, and SRPT.
View All Top Stocks by Price Target
Is BHC a Buy, Hold or Sell? See the POWR Ratings now!